Overview

pulseData focuses on improving the management of Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD) through the use of artificial intelligence and machine learning. The company provides healthcare providers with advanced data analytics tools that help identify high-risk patients, predict renal failure events, and track patient care. This enables healthcare providers to offer value-based care, which emphasizes high-quality treatment while keeping costs low. pulseData partners with healthcare institutions on a subscription basis, granting them access to its AI-driven platform that aids in identifying undiagnosed patients and optimizing care workflows. The goal of pulseData is to enhance patient outcomes and reduce unexpected medical expenses for both patients and providers.

Simplify's Take

What believers are saying

• Increased telehealth adoption enhances AI model accuracy for chronic disease prediction.
• AI integration in EHR systems improves data flow and patient monitoring.
• Rise of personalized medicine boosts demand for predictive analytics tools.

What critics are saying

• Emerging AI healthcare startups threaten pulseData's market share in kidney care.
• Potential inaccuracies in algorithms could misidentify high-risk patients, affecting outcomes.
• Data privacy concerns may undermine client confidence and lead to penalties.

What makes pulseData unique

• pulseData specializes in AI-driven kidney care, focusing on CKD and ESRD.
• The company offers predictive analytics to identify high-risk patients and optimize care.
• pulseData partners with healthcare providers to deliver value-based, cost-effective care.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$19.7M

Meets

Industry Average

Funded Over

2 Rounds

$16,500,000

Series A

Apr 2021

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.

Series A Funding Comparison

Meet Average

Industry standards

Ind Avg. $15M

$3.7M

$5M

$8.2M

$15M

$16.5M

$30M

View all funding stages